These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 10690549
1. The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B-cell lymphoma in immunodeficient mice. Wei BR, Ghetie MA, Vitetta ES. Clin Cancer Res; 2000 Feb; 6(2):631-42. PubMed ID: 10690549 [Abstract] [Full Text] [Related]
2. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons. Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ. Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):777-86. PubMed ID: 15701868 [Abstract] [Full Text] [Related]
3. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Burke PA, DeNardo SJ, Miers LA, Lamborn KR, Matzku S, DeNardo GL. Cancer Res; 2002 Aug 01; 62(15):4263-72. PubMed ID: 12154028 [Abstract] [Full Text] [Related]
4. Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. Ng B, Kramer E, Liebes L, Wasserheit C, Hochster H, Blank E, Ceriani R, Furmanski P. Cancer Res; 2001 Apr 01; 61(7):2996-3001. PubMed ID: 11306478 [Abstract] [Full Text] [Related]
5. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells. Li XF, Kinuya S, Yokoyama K, Koshida K, Mori H, Shiba K, Watanabe N, Shuke N, Michigishi T, Tonami N. Eur J Nucl Med Mol Imaging; 2002 Dec 01; 29(12):1669-74. PubMed ID: 12458402 [Abstract] [Full Text] [Related]
6. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK. Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098 [Abstract] [Full Text] [Related]
7. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH. Cancer Res; 2001 Jun 15; 61(12):4716-22. PubMed ID: 11406542 [Abstract] [Full Text] [Related]
8. Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts. Kinuya S, Kawashima A, Yokoyama K, Koshida K, Konishi S, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N. J Nucl Med; 2002 Aug 15; 43(8):1084-9. PubMed ID: 12163635 [Abstract] [Full Text] [Related]
9. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA. J Nucl Med; 2006 Jul 15; 47(7):1127-35. PubMed ID: 16818947 [Abstract] [Full Text] [Related]
10. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. Hernandez-Ilizaliturri FJ, Gowda A, Czuczman MS. Clin Adv Hematol Oncol; 2004 Sep 15; 2(9):606-18. PubMed ID: 16163245 [Abstract] [Full Text] [Related]
11. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy. Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM. Clin Cancer Res; 2000 Sep 15; 6(9):3621-8. PubMed ID: 10999754 [Abstract] [Full Text] [Related]
12. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. Revskaya E, Jongco AM, Sellers RS, Howell RC, Koba W, Guimaraes AJ, Nosanchuk JD, Casadevall A, Dadachova E. Clin Cancer Res; 2009 Apr 01; 15(7):2373-9. PubMed ID: 19293257 [Abstract] [Full Text] [Related]
13. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC. Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821 [Abstract] [Full Text] [Related]
14. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. Flavell DJ, Warnes SL, Bryson CJ, Field SA, Noss AL, Packham G, Flavell SU. Br J Haematol; 2006 Jul 01; 134(2):157-70. PubMed ID: 16771848 [Abstract] [Full Text] [Related]
15. Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J. J Nucl Med; 2000 Mar 01; 41(3):480-7. PubMed ID: 10716323 [Abstract] [Full Text] [Related]
18. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU. Br J Cancer; 2001 Feb 01; 84(4):571-8. PubMed ID: 11207056 [Abstract] [Full Text] [Related]
20. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy? Sautter-Bihl ML, Bihl H. Nuklearmedizin; 1994 Aug 01; 33(4):167-73. PubMed ID: 7971292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]